Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy

Jeffrey Graham; John Connor Wells; Shaan Dudani; Chun L. Gan; Frede Donskov; Jae lyun Lee; Christian K. Kollmannsberger; Luis Meza; Benoit Beuselinck; Aaron Hansen; Scott A. North; Georg A. Bjarnason; Nicolas Sayegh; Ravindran Kanesvaran; Lori A. Wood; Sebastien J. Hotte; Rana R. McKay; Toni K. Choueiri; Daniel Y.C. Heng

doi:10.1016/j.ejca.2022.05.002

Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy

Jeffrey Graham, John Connor Wells, Shaan Dudani, Chun L. Gan, Frede Donskov, Jae lyun Lee, Christian K. Kollmannsberger, Luis Meza, Benoit Beuselinck, Aaron Hansen, Scott A. North, Georg A. Bjarnason, Nicolas Sayegh, Ravindran Kanesvaran, Lori A. Wood, Sebastien J. Hotte, Rana R. McKay, Toni K. Choueiri, Daniel Y.C. Heng

Inernational Relations Division

Research output: Contribution to journal › Article › peer-review

24 Citations (Scopus)

Original language	English
Pages (from-to)	124-132
Number of pages	9
Journal	European Journal of Cancer
Volume	171
DOIs	https://doi.org/10.1016/j.ejca.2022.05.002
Publication status	Published - Aug 2022

ASJC Scopus Subject Areas

Oncology
Cancer Research

Keywords

Immune checkpoint inhibitor
Immunotherapy
Kidney cancer
Non-clear cell RCC
Renal cell carcinoma
Variant histology RCC

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2022.05.002

Cite this

Graham, J., Wells, J. C., Dudani, S., Gan, C. L., Donskov, F., Lee, J. L., Kollmannsberger, C. K., Meza, L., Beuselinck, B., Hansen, A., North, S. A., Bjarnason, G. A., Sayegh, N., Kanesvaran, R., Wood, L. A., Hotte, S. J., McKay, R. R., Choueiri, T. K., & Heng, D. Y. C. (2022). Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy. European Journal of Cancer, 171, 124-132. https://doi.org/10.1016/j.ejca.2022.05.002

Graham, J, Wells, JC, Dudani, S, Gan, CL, Donskov, F, Lee, JL, Kollmannsberger, CK, Meza, L, Beuselinck, B, Hansen, A, North, SA, Bjarnason, GA, Sayegh, N, Kanesvaran, R, Wood, LA, Hotte, SJ, McKay, RR, Choueiri, TK & Heng, DYC 2022, 'Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy', European Journal of Cancer, vol. 171, pp. 124-132. https://doi.org/10.1016/j.ejca.2022.05.002

@article{53ee48ecbfeb4936b3f220bcf9c7c165,

title = "Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy",

keywords = "Immune checkpoint inhibitor, Immunotherapy, Kidney cancer, Non-clear cell RCC, Renal cell carcinoma, Variant histology RCC",

author = "Jeffrey Graham and Wells, {John Connor} and Shaan Dudani and Gan, {Chun L.} and Frede Donskov and Lee, {Jae lyun} and Kollmannsberger, {Christian K.} and Luis Meza and Benoit Beuselinck and Aaron Hansen and North, {Scott A.} and Bjarnason, {Georg A.} and Nicolas Sayegh and Ravindran Kanesvaran and Wood, {Lori A.} and Hotte, {Sebastien J.} and McKay, {Rana R.} and Choueiri, {Toni K.} and Heng, {Daniel Y.C.}",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Ltd",

year = "2022",

month = aug,

doi = "10.1016/j.ejca.2022.05.002",

language = "English",

volume = "171",

pages = "124--132",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy

AU - Graham, Jeffrey

AU - Wells, John Connor

AU - Dudani, Shaan

AU - Gan, Chun L.

AU - Donskov, Frede

AU - Lee, Jae lyun

AU - Kollmannsberger, Christian K.

AU - Meza, Luis

AU - Beuselinck, Benoit

AU - Hansen, Aaron

AU - North, Scott A.

AU - Bjarnason, Georg A.

AU - Sayegh, Nicolas

AU - Kanesvaran, Ravindran

AU - Wood, Lori A.

AU - Hotte, Sebastien J.

AU - McKay, Rana R.

AU - Choueiri, Toni K.

AU - Heng, Daniel Y.C.

PY - 2022/8

Y1 - 2022/8

KW - Immune checkpoint inhibitor

KW - Immunotherapy

KW - Kidney cancer

KW - Non-clear cell RCC

KW - Renal cell carcinoma

KW - Variant histology RCC

UR - http://www.scopus.com/inward/record.url?scp=85132341096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85132341096&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2022.05.002

DO - 10.1016/j.ejca.2022.05.002

M3 - Article

C2 - 35717820

AN - SCOPUS:85132341096

SN - 0959-8049

VL - 171

SP - 124

EP - 132

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this